MIME-Version: 1.0
Content-Location: file:///C:/2C3946F8/bb9432cdd02c4dde8cca726a933b1068.htm
Content-Transfer-Encoding: quoted-printable
Content-Type: text/html; charset="utf-8"

<html xmlns:o=3D"urn:schemas-microsoft-com:office:office"
xmlns:dt=3D"uuid:C2F41010-65B3-11d1-A29F-00AA00C14882"
xmlns=3D"http://www.w3.org/TR/REC-html40">

<head>
<meta http-equiv=3DContent-Type content=3D"text/html; charset=3Dutf-8">
<meta name=3DProgId content=3DOneNote.File>
<meta name=3DGenerator content=3D"Microsoft OneNote 15">
<link id=3DMain-File rel=3DMain-File href=3Dbb9432cdd02c4dde8cca726a933b106=
8.htm>
<link rel=3DFile-List href=3D"bb9432cdd02c4dde8cca726a933b1068.files/fileli=
st.xml">
</head>

<body lang=3Dzh-TW style=3D'font-family:Calibri;font-size:11.0pt'>

<div style=3D'direction:ltr;border-width:100%'>

<div style=3D'direction:ltr;margin-top:0in;margin-left:0in;width:8.2708in'>

<div style=3D'direction:ltr;margin-top:0in;margin-left:0in;width:1.3854in'>

<p style=3D'margin:0in;font-family:"Microsoft JhengHei Light";font-size:20.=
0pt'
lang=3Den-US>高血脂</p>

</div>

<div style=3D'direction:ltr;margin-top:.0388in;margin-left:0in;width:2.7006=
in'>

<p style=3D'margin:0in;font-family:Calibri;font-size:10.0pt;color:#666666'
lang=3Den-US>Wednesday, February 26, 2025</p>

<p style=3D'margin:0in;font-family:Calibri;font-size:10.0pt;color:#666666'
lang=3Den-US>5:58 PM</p>

</div>

<div style=3D'direction:ltr;margin-top:.4in;margin-left:0in;width:8.2708in'>

<ul type=3Ddisc style=3D'direction:ltr;unicode-bidi:embed;margin-top:0in;
 margin-bottom:0in'>
 <li style=3D'margin-top:0;margin-bottom:0;vertical-align:middle;color:blac=
k'><span
     style=3D'font-family:"Microsoft JhengHei";font-size:16.0pt' lang=3Den-=
US>定義</span><span
     style=3D'font-family:"Microsoft JhengHei";font-size:16.0pt' lang=3Dzh-=
TW>（Definition）</span></li>
 <ul type=3Dcircle style=3D'direction:ltr;unicode-bidi:embed;margin-top:0in;
  margin-bottom:0in'>
  <li style=3D'margin-top:0;margin-bottom:0;vertical-align:middle;color:bla=
ck'
      lang=3Den-US><span style=3D'font-family:"Microsoft JhengHei";font-siz=
e:14.0pt;
      color:black'>血脂異常：</span><span style=3D'font-family:"Micros=
oft JhengHei";
      font-size:14.0pt;color:#2E75B5'>Total cholesterol、LDL-C 或triglyce=
ride升高</span><span
      style=3D'font-family:"Microsoft JhengHei";font-size:14.0pt;color:blac=
k'>，或</span><span
      style=3D'font-family:"Microsoft JhengHei";font-size:14.0pt;color:#2E7=
5B5'>HDL降低</span><span
      style=3D'font-family:"Microsoft JhengHei";font-size:14.0pt;color:blac=
k'>。</span></li>
 </ul>
 <ul type=3Dcircle style=3D'direction:ltr;unicode-bidi:embed;margin-top:0in;
  margin-bottom:0in'>
  <li style=3D'margin-top:0;margin-bottom:0;vertical-align:middle' lang=3De=
n-US><span
      style=3D'font-family:"Microsoft JhengHei";font-size:14.0pt;color:blac=
k'>LDL-C是主要的致動脈粥狀硬化膽固醇，與ASCVD（動脈粥=
硬化性心血管疾病，如冠狀動脈疾病
      CAD、腦中風） 相關。</span></li>
 </ul>
</ul>

<p style=3D'margin:0in;margin-left:.375in;font-family:"Microsoft JhengHei";
font-size:14.0pt;color:black' lang=3Den-US>&nbsp;</p>

<ul type=3Ddisc style=3D'direction:ltr;unicode-bidi:embed;margin-top:0in;
 margin-bottom:0in'>
 <li style=3D'margin-top:0;margin-bottom:0;vertical-align:middle;color:blac=
k'><span
     style=3D'font-family:"Microsoft JhengHei";font-size:16.0pt' lang=3Den-=
US>流行病學</span><span
     style=3D'font-family:"Microsoft JhengHei";font-size:16.0pt' lang=3Dzh-=
TW>（Epidemiology）</span></li>
 <ul type=3Dcircle style=3D'direction:ltr;unicode-bidi:embed;margin-top:0in;
  margin-bottom:0in'>
  <li style=3D'margin-top:0;margin-bottom:0;vertical-align:middle' lang=3De=
n-US><span
      style=3D'font-family:"Microsoft JhengHei";font-size:14.0pt'>根據中=
華民國血脂及動脈硬化學會2022年指引：</span></li>
  <ul type=3Ddisc style=3D'direction:ltr;unicode-bidi:embed;margin-top:0in;
   margin-bottom:0in'>
   <li style=3D'margin-top:0;margin-bottom:0;vertical-align:middle;color:bl=
ack'
       lang=3Den-US><span style=3D'font-family:"Microsoft JhengHei";font-si=
ze:11.0pt'>高血脂症在台灣的流行病學資料顯示，隨著生活=
式的改變以及人口老化，心血管疾病的風險逐年上升。=
成人中，約
       30% 以上的人群存在某種形式的高血脂（例如：高總=
固醇、高LDL-C、低HDL-C 或高三酸甘油酯），並且這一比=
隨著年齡的增長而上升。</span></li>
   <li style=3D'margin-top:0;margin-bottom:0;vertical-align:middle;color:bl=
ack'
       lang=3Den-US><span style=3D'font-family:"Microsoft JhengHei";font-si=
ze:11.0pt'>男性通常在較年輕的年齡段出現高血脂問題，而=
性則多見於更年期後，這是由於女性在更年期後，隨著=
激素水平下降，對心血管的保護作用減弱，導致膽固醇=
平的升高。</span></li>
   <li style=3D'margin-top:0;margin-bottom:0;vertical-align:middle;color:bl=
ack'
       lang=3Den-US><span style=3D'font-family:"Microsoft JhengHei";font-si=
ze:11.0pt'>高血脂與多種心血管疾病密切相關，包括冠狀動=
疾病（Coronary
       Artery Disease）、外周動脈疾病（Peripheral Artery Disease=
、缺血性中風（Ischemic
       Stroke）等。</span></li>
   <li style=3D'margin-top:0;margin-bottom:0;vertical-align:middle;color:bl=
ack'
       lang=3Den-US><span style=3D'font-family:"Microsoft JhengHei";font-si=
ze:11.0pt'>研究顯示，患有高血脂的個體，其心血管事件的=
險大大增加，且對高風險群體（如糖尿病、吸煙者、高=
壓者）的影響尤為顯著。</span></li>
  </ul>
 </ul>
</ul>

<p style=3D'margin:0in;margin-left:.375in;font-family:"Microsoft JhengHei";
font-size:11.0pt;color:black' lang=3Den-US>&nbsp;</p>

<ul type=3Ddisc style=3D'direction:ltr;unicode-bidi:embed;margin-top:0in;
 margin-bottom:0in'>
 <li style=3D'margin-top:0;margin-bottom:0;vertical-align:middle;color:blac=
k'
     lang=3Den-US><span style=3D'font-family:"Microsoft JhengHei";font-size=
:16.0pt'>Lipoprotein
     類別與功能</span></li>
</ul>

<div style=3D'direction:ltr'>

<table border=3D1 cellpadding=3D0 cellspacing=3D0 valign=3Dtop style=3D'dir=
ection:ltr;
 border-collapse:collapse;border-style:solid;border-color:#A3A3A3;border-wi=
dth:
 1pt;margin-left:.3333in' title=3D"" summary=3D"">
 <tr>
  <td style=3D'border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:2.3895in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style=3D'margin:0in;font-family:"Microsoft JhengHei";font-size:11.0pt;
  color:black;text-align:center' lang=3Den-US>Lipoprotein 類型</p>
  </td>
  <td style=3D'border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:1.3951in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style=3D'margin:0in;font-family:"Microsoft JhengHei";font-size:11.0pt;
  color:black;text-align:center' lang=3Den-US>主要成分</p>
  </td>
  <td style=3D'border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:2.1798in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style=3D'margin:0in;font-family:"Microsoft JhengHei";font-size:11.0pt;
  color:black;text-align:center' lang=3Den-US>功能</p>
  </td>
  <td style=3D'border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:1.6208in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style=3D'margin:0in;font-family:"Microsoft JhengHei";font-size:11.0pt;
  color:black;text-align:center' lang=3Den-US>關鍵 Apoprotein</p>
  </td>
 </tr>
 <tr>
  <td style=3D'border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:2.3895in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style=3D'margin:0in;font-family:"Microsoft JhengHei";font-size:11.0pt;
  color:black' lang=3Den-US>Chylomicrons</p>
  </td>
  <td style=3D'border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:1.3951in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style=3D'margin:0in;font-family:"Microsoft JhengHei";font-size:11.0pt;
  color:black' lang=3Den-US>TG（90%）</p>
  </td>
  <td style=3D'border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:2.1798in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style=3D'margin:0in;font-family:"Microsoft JhengHei";font-size:11.0pt;
  color:black' lang=3Den-US>攜帶飲食脂肪（TG）從腸道到肝臟</p>
  </td>
  <td style=3D'border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:1.6208in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style=3D'margin:0in;font-family:"Microsoft JhengHei";font-size:11.0pt;
  color:black' lang=3Den-US>ApoB-48、ApoC-II、ApoE</p>
  </td>
 </tr>
 <tr>
  <td style=3D'border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:2.3895in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style=3D'margin:0in;font-family:"Microsoft JhengHei";font-size:11.0pt;
  color:black' lang=3Den-US>VLDL (Very-Low-Density Lipoprotein)</p>
  </td>
  <td style=3D'border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:1.3951in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style=3D'margin:0in;font-family:"Microsoft JhengHei";font-size:11.0pt;
  color:black' lang=3Den-US>TG（55%）</p>
  </td>
  <td style=3D'border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:2.1798in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style=3D'margin:0in;font-family:"Microsoft JhengHei";font-size:11.0pt;
  color:black' lang=3Den-US>肝臟合成，運輸內源性TG到周邊組織=
</p>
  </td>
  <td style=3D'border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:1.6208in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style=3D'margin:0in;font-family:"Microsoft JhengHei";font-size:11.0pt;
  color:black' lang=3Den-US>ApoB-100、ApoC-II、ApoE</p>
  </td>
 </tr>
 <tr>
  <td style=3D'border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:2.3895in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style=3D'margin:0in;font-family:"Microsoft JhengHei";font-size:11.0pt;
  color:black' lang=3Den-US>IDL (Intermediate-Density Lipoprotein)</p>
  </td>
  <td style=3D'border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:1.3951in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style=3D'margin:0in;font-family:"Microsoft JhengHei";font-size:11.0pt;
  color:black' lang=3Den-US>TG（40%）</p>
  </td>
  <td style=3D'border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:2.1798in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style=3D'margin:0in;font-family:"Microsoft JhengHei";font-size:11.0pt;
  color:black' lang=3Den-US>VLDL 代謝中間產物，可轉換為 LDL</p>
  </td>
  <td style=3D'border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:1.6208in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style=3D'margin:0in;font-family:"Microsoft JhengHei";font-size:11.0pt;
  color:black' lang=3Den-US>ApoB-100、ApoE</p>
  </td>
 </tr>
 <tr>
  <td style=3D'border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:2.409in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style=3D'margin:0in;font-family:"Microsoft JhengHei";font-size:11.0pt;
  color:black' lang=3Den-US>LDL (Low-Density Lipoprotein)</p>
  </td>
  <td style=3D'border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:1.3951in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style=3D'margin:0in;font-family:"Microsoft JhengHei";font-size:11.0pt;
  color:black' lang=3Den-US>Cholesterol（50%）</p>
  </td>
  <td style=3D'border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:2.1798in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style=3D'margin:0in;font-family:"Microsoft JhengHei";font-size:11.0pt;
  color:black' lang=3Den-US>運輸膽固醇至周邊組織</p>
  </td>
  <td style=3D'border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:1.4895in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style=3D'margin:0in;font-family:"Microsoft JhengHei";font-size:11.0pt;
  color:black' lang=3Den-US>ApoB-100</p>
  </td>
 </tr>
 <tr>
  <td style=3D'border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:2.3895in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style=3D'margin:0in;font-family:"Microsoft JhengHei";font-size:11.0pt;
  color:black' lang=3Den-US>HDL (High-Density Lipoprotein)</p>
  </td>
  <td style=3D'border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:1.3951in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style=3D'margin:0in;font-family:"Microsoft JhengHei";font-size:11.0pt;
  color:black' lang=3Den-US>Protein（50%）</p>
  </td>
  <td style=3D'border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:2.1986in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style=3D'margin:0in;font-family:"Microsoft JhengHei";font-size:11.0pt;
  color:black' lang=3Den-US>反向膽固醇運輸，將膽固醇帶回肝=
</p>
  </td>
  <td style=3D'border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:1.6208in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style=3D'margin:0in;font-family:"Microsoft JhengHei";font-size:11.0pt;
  color:black' lang=3Den-US>ApoA-I、ApoA-II</p>
  </td>
 </tr>
</table>

</div>

<h3 style=3D'margin:0in;margin-left:.375in;font-family:"Microsoft JhengHei";
font-size:16.0pt;color:black' lang=3Den-US>&nbsp;</h3>

<ul type=3Ddisc style=3D'direction:ltr;unicode-bidi:embed;margin-top:0in;
 margin-bottom:0in'>
 <li style=3D'margin-top:0;margin-bottom:0;vertical-align:middle;color:blac=
k'
     lang=3Den-US><span style=3D'font-family:"Microsoft JhengHei";font-size=
:16.0pt'>病理生理（Pathophysiology）</span></li>
 <ul type=3Dcircle style=3D'direction:ltr;unicode-bidi:embed;margin-top:0in;
  margin-bottom:0in'>
  <li style=3D'margin-top:0;margin-bottom:0;vertical-align:middle' lang=3De=
n-US><span
      style=3D'font-family:"Microsoft JhengHei";font-size:14.0pt'>動脈粥=
樣硬化：</span><span
      style=3D'font-family:"Microsoft JhengHei";font-size:14.0pt;color:#2E7=
5B5'>高LDL-C會積聚於血管壁內</span><span
      style=3D'font-family:"Microsoft JhengHei";font-size:14.0pt'>，形成=
動脈粥樣硬化斑塊，進一步引發血管狹窄或閉塞，影響血=
流，增加心血管事件風險（心肌梗死、缺血性中風）。</s=
pan></li>
  <li style=3D'margin-top:0;margin-bottom:0;vertical-align:middle' lang=3De=
n-US><span
      style=3D'font-family:"Microsoft JhengHei";font-size:14.0pt'>低HDL-C=
低密度脂蛋白膽固醇（HDL-C）具有反向膽固醇運輸作用=
幫助清除血管內的膽固醇。HDL-C水平低時，會加重心血管=
風險。</span></li>
  <li style=3D'margin-top:0;margin-bottom:0;vertical-align:middle' lang=3De=
n-US><span
      style=3D'font-family:"Microsoft JhengHei";font-size:14.0pt'>高三酸=
甘油酯（TG）：高TG與心血管疾病風險相關，尤其是與動=
粥樣硬化密切關聯。高TG還可能引發急性胰臟炎。</span></=
li>
 </ul>
</ul>

<p style=3D'margin:0in;font-family:"Microsoft JhengHei";font-size:11.0pt;
color:black' lang=3Den-US>&nbsp;</p>

<ul type=3Ddisc style=3D'direction:ltr;unicode-bidi:embed;margin-top:0in;
 margin-bottom:0in'>
 <li style=3D'margin-top:0;margin-bottom:0;vertical-align:middle;color:blac=
k'
     lang=3Den-US><span style=3D'font-family:"Microsoft JhengHei";font-size=
:16.0pt'>病因</span></li>
 <ul type=3Dcircle style=3D'direction:ltr;unicode-bidi:embed;margin-top:0in;
  margin-bottom:0in'>
  <li style=3D'margin-top:0;margin-bottom:0;vertical-align:middle' lang=3De=
n-US><span
      style=3D'font-family:"Microsoft JhengHei";font-size:14.0pt'>Primary=
原發性，遺傳性）</span></li>
  <ul type=3Ddisc style=3D'direction:ltr;unicode-bidi:embed;margin-top:0in;
   margin-bottom:0in'>
   <li style=3D'margin-top:0;margin-bottom:0;vertical-align:middle;color:bl=
ack'
       lang=3Den-US><span style=3D'font-family:"Microsoft JhengHei";font-si=
ze:11.0pt'>Familial
       combined hypercholesterolemia（家族性混合型高膽固醇血症=
）</span></li>
   <li style=3D'margin-top:0;margin-bottom:0;vertical-align:middle;color:bl=
ack'
       lang=3Den-US><span style=3D'font-family:"Microsoft JhengHei";font-si=
ze:11.0pt'>Familial
       hypertriglyceridemia（家族性高三酸甘油酯血症）</span></=
li>
  </ul>
  <li style=3D'margin-top:0;margin-bottom:0;vertical-align:middle;margin-to=
p:
      5pt;margin-bottom:5pt' lang=3Den-US><span style=3D'font-family:"Micro=
soft JhengHei";
      font-size:14.0pt;color:black'>Secondary（繼發性）</span></li>
  <ul type=3Ddisc style=3D'direction:ltr;unicode-bidi:embed;margin-top:0in;
   margin-bottom:0in'>
   <li style=3D'margin-top:0;margin-bottom:0;vertical-align:middle;color:bl=
ack'
       lang=3Den-US><span style=3D'font-family:"Microsoft JhengHei";font-si=
ze:11.0pt'>代謝性疾病：DM（糖尿病）、hypothyroidism（甲狀腺=
功能低下）</span></li>
   <li style=3D'margin-top:0;margin-bottom:0;vertical-align:middle;color:bl=
ack'
       lang=3Den-US><span style=3D'font-family:"Microsoft JhengHei";font-si=
ze:11.0pt'>肝腎疾病：Cholestatic
       liver disease（膽汁鬱積性肝病）、nephrotic syndrome（腎=
症候群）、chronic renal
       disease（慢性腎臟病）</span></li>
   <li style=3D'margin-top:0;margin-bottom:0;vertical-align:middle;color:bl=
ack'
       lang=3Den-US><span style=3D'font-family:"Microsoft JhengHei";font-si=
ze:11.0pt'>生活習慣：肥胖、吸菸、過量飲酒</span></li>
   <li style=3D'margin-top:0;margin-bottom:0;vertical-align:middle;color:bl=
ack'
       lang=3Den-US><span style=3D'font-family:"Microsoft JhengHei";font-si=
ze:11.0pt'>藥物：</span></li>
   <ul type=3Ddisc style=3D'direction:ltr;unicode-bidi:embed;margin-top:0in;
    margin-bottom:0in'>
    <li style=3D'margin-top:0;margin-bottom:0;vertical-align:middle;color:b=
lack'
        lang=3Den-US><span style=3D'font-family:"Microsoft JhengHei";font-s=
ize:
        11.0pt'>Thiazide diuretics</span></li>
    <li style=3D'margin-top:0;margin-bottom:0;vertical-align:middle;color:b=
lack'
        lang=3Den-US><span style=3D'font-family:"Microsoft JhengHei";font-s=
ize:
        11.0pt'>β-blockers</span></li>
    <li style=3D'margin-top:0;margin-bottom:0;vertical-align:middle;color:b=
lack'
        lang=3Den-US><span style=3D'font-family:"Microsoft JhengHei";font-s=
ize:
        11.0pt'>口服避孕藥</span></li>
    <li style=3D'margin-top:0;margin-bottom:0;vertical-align:middle;color:b=
lack'
        lang=3Den-US><span style=3D'font-family:"Microsoft JhengHei";font-s=
ize:
        11.0pt'>Clozapine（抗精神病藥</span></li>
   </ul>
  </ul>
 </ul>
</ul>

<ul type=3Ddisc style=3D'direction:ltr;unicode-bidi:embed;margin-top:0in;
 margin-bottom:0in'>
 <li style=3D'margin-top:0;margin-bottom:0;vertical-align:middle' lang=3Den=
-US><span
     style=3D'font-family:"Microsoft JhengHei";font-size:16.0pt;color:black=
'>病史與理學檢查（History/PE）</span></li>
 <ul type=3Dcircle style=3D'direction:ltr;unicode-bidi:embed;margin-top:0in;
  margin-bottom:0in'>
  <li style=3D'margin-top:0;margin-bottom:0;vertical-align:middle;margin-to=
p:
      5pt;margin-bottom:5pt' lang=3Den-US><span style=3D'font-family:"Micro=
soft JhengHei";
      font-size:14.0pt;color:black'>大多數患者無明顯症狀</span></=
li>
  <li style=3D'margin-top:0;margin-bottom:0;vertical-align:middle;margin-to=
p:
      5pt;margin-bottom:5pt' lang=3Den-US><span style=3D'font-family:"Micro=
soft JhengHei";
      font-size:14.0pt;color:black'>嚴重高脂血症可能有體徵</span=
></li>
  <ul type=3Ddisc style=3D'direction:ltr;unicode-bidi:embed;margin-top:0in;
   margin-bottom:0in'>
   <li style=3D'margin-top:0;margin-bottom:0;vertical-align:middle;color:bl=
ack'
       lang=3Den-US><span style=3D'font-family:"Microsoft JhengHei";font-si=
ze:11.0pt'>Xanthomata（黃瘤）：</span></li>
   <ul type=3Ddisc style=3D'direction:ltr;unicode-bidi:embed;margin-top:0in;
    margin-bottom:0in'>
    <li style=3D'margin-top:0;margin-bottom:0;vertical-align:middle;color:b=
lack'
        lang=3Den-US><span style=3D'font-family:"Microsoft JhengHei";font-s=
ize:
        11.0pt'>Eruptive xanthomas（爆發性黃瘤）：瘙癢性結節</=
span></li>
    <li style=3D'margin-top:0;margin-bottom:0;vertical-align:middle;color:b=
lack'
        lang=3Den-US><span style=3D'font-family:"Microsoft JhengHei";font-s=
ize:
        11.0pt'>Tuberous xanthomas（結節性黃瘤）：肘部、膝部=
節</span></li>
    <li style=3D'margin-top:0;margin-bottom:0;vertical-align:middle;color:b=
lack'
        lang=3Den-US><span style=3D'font-family:"Microsoft JhengHei";font-s=
ize:
        11.0pt'>Palmar xanthomas（掌紋黃瘤）：掌紋橘色條紋</sp=
an></li>
   </ul>
   <li style=3D'margin-top:0;margin-bottom:0;vertical-align:middle;color:bl=
ack'
       lang=3Den-US><span style=3D'font-family:"Microsoft JhengHei";font-si=
ze:11.0pt'>Xanthelasma（眼瞼黃斑瘤）：眼周黃色脂肪沉積</spa=
n></li>
   <li style=3D'margin-top:0;margin-bottom:0;vertical-align:middle;color:bl=
ack'
       lang=3Den-US><span style=3D'font-family:"Microsoft JhengHei";font-si=
ze:11.0pt'>Lipemia
       retinalis（乳糜血症性視網膜病變）：視網膜血管呈=
白色</span></li>
   <li style=3D'margin-top:0;margin-bottom:0;vertical-align:middle;color:bl=
ack'
       lang=3Den-US><span style=3D'font-family:"Microsoft JhengHei";font-si=
ze:11.0pt'>Corneal
       arcus（角膜弧）：角膜基質脂質沉積</span></li>
  </ul>
  <li style=3D'margin-top:0;margin-bottom:0;vertical-align:middle;margin-to=
p:
      5pt;margin-bottom:5pt' lang=3Den-US><span style=3D'font-family:"Micro=
soft JhengHei";
      font-size:14.0pt;color:black'>嚴重高三酸甘油酯血症（&gt;500
      mg/dL）可能導致急性胰臟炎（pancreatitis）</span></li>
  <li style=3D'margin-top:0;margin-bottom:0;vertical-align:middle;margin-to=
p:
      5pt;margin-bottom:5pt' lang=3Den-US><span style=3D'font-family:"Micro=
soft JhengHei";
      font-size:14.0pt;color:black'>可能有家族性高脂血症（famili=
al hyperlipidemia）病史</span></li>
 </ul>
 <li style=3D'margin-top:0;margin-bottom:0;vertical-align:middle;margin-top=
:5pt;
     margin-bottom:5pt' lang=3Den-US><span style=3D'font-family:"Microsoft =
JhengHei";
     font-size:16.0pt;color:black'>繼發性高脂血症常見病因</span>=
</li>
 <ul type=3Dcircle style=3D'direction:ltr;unicode-bidi:embed;margin-top:0in;
  margin-bottom:0in'>
  <li style=3D'margin-top:0;margin-bottom:0;vertical-align:middle' lang=3De=
n-US><span
      style=3D'font-family:"Microsoft JhengHei";font-size:14.0pt;color:blac=
k'>Cushing
      syndrome</span></li>
  <li style=3D'margin-top:0;margin-bottom:0;vertical-align:middle' lang=3De=
n-US><span
      style=3D'font-family:"Microsoft JhengHei";font-size:14.0pt;color:blac=
k'>Hypothyroidism（甲狀腺功能低下）</span></li>
  <li style=3D'margin-top:0;margin-bottom:0;vertical-align:middle' lang=3De=
n-US><span
      style=3D'font-family:"Microsoft JhengHei";font-size:14.0pt;color:blac=
k'>Nephrotic
      syndrome（腎病症候群）</span></li>
  <li style=3D'margin-top:0;margin-bottom:0;vertical-align:middle' lang=3De=
n-US><span
      style=3D'font-family:"Microsoft JhengHei";font-size:14.0pt;color:blac=
k'>Cholestasis（膽汁鬱積）</span></li>
 </ul>
</ul>

<p style=3D'margin:0in;margin-left:.375in;font-family:Calibri;font-size:11.=
0pt'>&nbsp;</p>

<ul type=3Ddisc style=3D'direction:ltr;unicode-bidi:embed;margin-top:0in;
 margin-bottom:0in'>
 <li style=3D'margin-top:0;margin-bottom:0;vertical-align:middle;margin-top=
:5pt;
     margin-bottom:5pt' lang=3Den-US><span style=3D'font-family:"Microsoft =
JhengHei";
     font-size:16.0pt;color:black'>篩檢建議</span></li>
 <ul type=3Dcircle style=3D'direction:ltr;unicode-bidi:embed;margin-top:0in;
  margin-bottom:0in'>
  <li style=3D'margin-top:0;margin-bottom:0;vertical-align:middle;color:bla=
ck'><span
      style=3D'font-family:"Microsoft JhengHei";font-size:14.0pt'>高血脂=
篩檢建議（Dyslipidemia
      Screening）</span></li>
  <ul type=3Ddisc style=3D'direction:ltr;unicode-bidi:embed;margin-top:0in;
   margin-bottom:0in'>
   <li style=3D'margin-top:0;margin-bottom:0;vertical-align:middle;color:bl=
ack'
       lang=3Den-US><span style=3D'font-family:"Microsoft JhengHei";font-si=
ze:11.0pt'>依據
       2023 ACC/AHA、2022 ESC/EAS 及 2022
       台灣動脈硬化學會（TAS）指南，高血脂的篩檢應考=
年齡、危險因子、家族病史，篩檢方法主要以空腹或非=
腹血脂檢測（Lipid Profile）
       為主。</span></li>
  </ul>
 </ul>
</ul>

<p style=3D'margin:0in;margin-left:1.125in;font-family:"Microsoft JhengHei";
font-size:11.0pt;color:black' lang=3Den-US>&nbsp;</p>

<ul type=3Ddisc style=3D'direction:ltr;unicode-bidi:embed;margin-top:0in;
 margin-bottom:0in'>
 <li style=3D'margin-top:0;margin-bottom:0;vertical-align:middle;color:blac=
k'><span
     style=3D'font-family:"Microsoft JhengHei";font-size:16.0pt'>一般成=
族群篩檢建議</span></li>
</ul>

<div style=3D'direction:ltr'>

<table border=3D1 cellpadding=3D0 cellspacing=3D0 valign=3Dtop style=3D'dir=
ection:ltr;
 border-collapse:collapse;border-style:solid;border-color:#A3A3A3;border-wi=
dth:
 1pt;margin-left:.3333in' title=3D"" summary=3D"">
 <tr>
  <td style=3D'border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:1.277in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style=3D'margin:0in;font-family:"Microsoft JhengHei";font-size:11.0pt;
  color:black;text-align:center'>族群</p>
  </td>
  <td style=3D'border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:6.1972in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style=3D'margin:0in;font-family:"Microsoft JhengHei";font-size:11.0pt;
  color:black;text-align:center'>篩檢建議</p>
  </td>
 </tr>
 <tr>
  <td style=3D'border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:1.277in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style=3D'margin:0in;font-family:"Microsoft JhengHei";font-size:11.0pt;
  color:black'>20-39 歲成人</p>
  </td>
  <td style=3D'border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:6.2666in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style=3D'margin:0in;font-family:"Microsoft JhengHei";font-size:11.0pt;
  color:black'>有心血管危險因子者（如糖尿病、肥胖、吸菸=
、高血壓、家族史），應每 4-6 年檢測 1 次。</p>
  </td>
 </tr>
 <tr>
  <td style=3D'border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:1.277in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style=3D'margin:0in;font-family:"Microsoft JhengHei";font-size:11.0pt;
  color:black'>40-75 歲成人</p>
  </td>
  <td style=3D'border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:6.1972in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style=3D'margin:0in;font-family:"Microsoft JhengHei";font-size:11.0pt;
  color:black'>所有人皆應篩檢，至少每4-6年1次，若為高風=
族群（如糖尿病或心血管疾病）應每 1-2 年檢測 1 次。</p>
  </td>
 </tr>
 <tr>
  <td style=3D'border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:1.277in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style=3D'margin:0in;font-family:"Microsoft JhengHei";font-size:11.0pt;
  color:black'>&gt; 75 歲老年人</p>
  </td>
  <td style=3D'border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:6.1972in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style=3D'margin:0in;font-family:"Microsoft JhengHei";font-size:11.0pt;
  color:black'>仍應持續監測，但應根據個人健康狀況與餘命=
決定是否積極治療。</p>
  </td>
 </tr>
</table>

</div>

<h2 style=3D'margin:0in;margin-left:.375in;font-family:Calibri;font-size:14=
.0pt;
color:black'>&nbsp;</h2>

<ul type=3Ddisc style=3D'direction:ltr;unicode-bidi:embed;margin-top:0in;
 margin-bottom:0in'>
 <li style=3D'margin-top:0;margin-bottom:0;vertical-align:middle;color:blac=
k'
     lang=3Den-US><span style=3D'font-family:"Microsoft JhengHei";font-size=
:16.0pt'>高風險族群的篩檢建議</span></li>
 <ul type=3Dcircle style=3D'direction:ltr;unicode-bidi:embed;margin-top:0in;
  margin-bottom:0in'>
  <li style=3D'margin-top:0;margin-bottom:0;vertical-align:middle;margin-to=
p:
      5pt;margin-bottom:5pt;color:black' lang=3Den-US><span style=3D'font-f=
amily:
      "Microsoft JhengHei";font-size:14.0pt'>以下高風險族群應每1-2=
 年檢測1次，必要時可每年追蹤： </span></li>
  <ul type=3Ddisc style=3D'direction:ltr;unicode-bidi:embed;margin-top:0in;
   margin-bottom:0in'>
   <li style=3D'margin-top:0;margin-bottom:0;vertical-align:middle;margin-t=
op:
       5pt;margin-bottom:5pt;color:black'><span style=3D'font-family:"Micro=
soft JhengHei";
       font-size:11.0pt' lang=3Den-US>家族性高膽固醇血症（FH）=
族史（1 等親LDL </span><span
       style=3D'font-family:"Cambria Math";font-size:11.0pt' lang=3D"x-IV_m=
athan">≥</span><span
       style=3D'font-family:"Microsoft JhengHei";font-size:11.0pt' lang=3De=
n-US>
       190 mg/dL或早發心血管病史）</span></li>
   <li style=3D'margin-top:0;margin-bottom:0;vertical-align:middle;margin-t=
op:
       5pt;margin-bottom:5pt;color:black' lang=3Den-US><span style=3D'font-=
family:
       "Microsoft JhengHei";font-size:11.0pt'>糖尿病（Diabetes Mellitus=
, DM）</span></li>
   <li style=3D'margin-top:0;margin-bottom:0;vertical-align:middle;margin-t=
op:
       5pt;margin-bottom:5pt;color:black' lang=3Den-US><span style=3D'font-=
family:
       "Microsoft JhengHei";font-size:11.0pt'>慢性腎病（Chronic Kidney=
 Disease, CKD,
       eGFR &lt; 60）</span></li>
   <li style=3D'margin-top:0;margin-bottom:0;vertical-align:middle;margin-t=
op:
       5pt;margin-bottom:5pt;color:black' lang=3Den-US><span style=3D'font-=
family:
       "Microsoft JhengHei";font-size:11.0pt'>動脈粥樣硬化性心血=
疾病（ASCVD）病史</span></li>
   <li style=3D'margin-top:0;margin-bottom:0;vertical-align:middle;margin-t=
op:
       5pt;margin-bottom:5pt;color:black' lang=3Den-US><span style=3D'font-=
family:
       "Microsoft JhengHei";font-size:11.0pt'>高血壓（Hypertension）</=
span></li>
   <li style=3D'margin-top:0;margin-bottom:0;vertical-align:middle;margin-t=
op:
       5pt;margin-bottom:5pt;color:black'><span style=3D'font-family:"Micro=
soft JhengHei";
       font-size:11.0pt' lang=3Den-US>肥胖（BMI </span><span style=3D'fo=
nt-family:
       "Cambria Math";font-size:11.0pt' lang=3D"x-IV_mathan">≥</span><span
       style=3D'font-family:"Microsoft JhengHei";font-size:11.0pt' lang=3De=
n-US>
       30）</span></li>
   <li style=3D'margin-top:0;margin-bottom:0;vertical-align:middle;margin-t=
op:
       5pt;margin-bottom:5pt;color:black' lang=3Den-US><span style=3D'font-=
family:
       "Microsoft JhengHei";font-size:11.0pt'>吸菸者</span></li>
   <li style=3D'margin-top:0;margin-bottom:0;vertical-align:middle;margin-t=
op:
       5pt;margin-bottom:5pt;color:black'><span style=3D'font-family:"Micro=
soft JhengHei";
       font-size:11.0pt' lang=3Den-US>高膽固醇血症（LDL-C </span><sp=
an style=3D'font-family:
       "Cambria Math";font-size:11.0pt' lang=3D"x-IV_mathan">≥</span><span
       style=3D'font-family:"Microsoft JhengHei";font-size:11.0pt' lang=3De=
n-US>
       190 mg/dL）</span></li>
  </ul>
 </ul>
 <li style=3D'margin-top:0;margin-bottom:0;vertical-align:middle;margin-top=
:5pt;
     margin-bottom:5pt;color:black' lang=3Den-US><span style=3D'font-family=
:"Microsoft JhengHei";
     font-size:16.0pt'>診斷（Diagnosis）</span></li>
 <ul type=3Dcircle style=3D'direction:ltr;unicode-bidi:embed;margin-top:0in;
  margin-bottom:0in'>
  <li style=3D'margin-top:0;margin-bottom:0;vertical-align:middle;margin-to=
p:
      5pt;margin-bottom:5pt' lang=3Den-US><span style=3D'font-family:"Micro=
soft JhengHei";
      font-size:14.0pt;color:black'>首選檢查：Lipid profile（血脂=
析）</span></li>
  <ul type=3Ddisc style=3D'direction:ltr;unicode-bidi:embed;margin-top:0in;
   margin-bottom:0in'>
   <li style=3D'margin-top:0;margin-bottom:0;vertical-align:middle;color:bl=
ack'
       lang=3Den-US><span style=3D'font-family:"Microsoft JhengHei";font-si=
ze:11.0pt;
       color:#C00000'>Total cholesterol ↑</span></li>
   <li style=3D'margin-top:0;margin-bottom:0;vertical-align:middle;color:bl=
ack'
       lang=3Den-US><span style=3D'font-family:"Microsoft JhengHei";font-si=
ze:11.0pt;
       color:#C00000'>LDL-C ↑</span></li>
   <li style=3D'margin-top:0;margin-bottom:0;vertical-align:middle;color:bl=
ack'
       lang=3Den-US><span style=3D'font-family:"Microsoft JhengHei";font-si=
ze:11.0pt;
       color:#C00000'>Triglycerides ↑</span></li>
   <li style=3D'margin-top:0;margin-bottom:0;vertical-align:middle;color:bl=
ack'
       lang=3Den-US><span style=3D'font-family:"Microsoft JhengHei";font-si=
ze:11.0pt;
       color:#C00000'>HDL ↓</span></li>
  </ul>
 </ul>
</ul>

<ul type=3Ddisc style=3D'direction:ltr;unicode-bidi:embed;margin-top:0in;
 margin-bottom:0in'>
 <li style=3D'margin-top:0;margin-bottom:0;vertical-align:middle;margin-top=
:5pt;
     margin-bottom:5pt' lang=3Den-US><span style=3D'font-family:"Microsoft =
JhengHei";
     font-size:16.0pt;color:black'>診斷標準：</span></li>
 <ul type=3Dcircle style=3D'direction:ltr;unicode-bidi:embed;margin-top:0in;
  margin-bottom:0in'>
  <li style=3D'margin-top:0;margin-bottom:0;vertical-align:middle;color:bla=
ck'
      lang=3Den-US><span style=3D'font-family:"Microsoft JhengHei";font-siz=
e:14.0pt;
      color:#C00000'>總膽固醇（Total Cholesterol, TC）</span><span st=
yle=3D'font-family:
      "Cambria Math";font-size:14.0pt;color:#C00000'>≥</span><span
      style=3D'font-family:"Microsoft JhengHei";font-size:14.0pt;color:#C00=
000'>
      200 mg/dL</span></li>
  <li style=3D'margin-top:0;margin-bottom:0;vertical-align:middle;color:bla=
ck'
      lang=3Den-US><span style=3D'font-family:"Microsoft JhengHei";font-siz=
e:14.0pt;
      color:#C00000'>低密度脂蛋白（LDL-C）</span><span style=3D'fon=
t-family:"Cambria Math";
      font-size:14.0pt;color:#C00000'>≥</span><span style=3D'font-family:=
"Microsoft JhengHei";
      font-size:14.0pt;color:#C00000'> 130 mg/dL</span><span style=3D'font-=
family:
      "Microsoft JhengHei";font-size:14.0pt;color:black'>（建議控制在=
 &lt; 100
      mg/dL，對於高風險者 &lt; 70 mg/dL）</span></li>
  <li style=3D'margin-top:0;margin-bottom:0;vertical-align:middle;color:bla=
ck'
      lang=3Den-US><span style=3D'font-family:"Microsoft JhengHei";font-siz=
e:14.0pt;
      color:#C00000'>高密度脂蛋白（HDL-C）&lt; 40 mg/dL（男性）=
或 &lt; 50 mg/dL（女性）</span></li>
  <li style=3D'margin-top:0;margin-bottom:0;vertical-align:middle;color:bla=
ck'
      lang=3Den-US><span style=3D'font-family:"Microsoft JhengHei";font-siz=
e:14.0pt;
      color:#C00000'>三酸甘油酯（Triglycerides, TG）</span><span sty=
le=3D'font-family:
      "Cambria Math";font-size:14.0pt;color:#C00000'>≥</span><span
      style=3D'font-family:"Microsoft JhengHei";font-size:14.0pt;color:#C00=
000'>
      150 mg/dL</span><span style=3D'font-family:"Microsoft JhengHei";font-=
size:
      14.0pt;color:black'>（嚴重高TG &gt; 500 mg/dL 會增加胰臟炎=
險）</span></li>
 </ul>
</ul>

<p style=3D'margin:0in;margin-left:.375in;font-family:"Microsoft JhengHei";
font-size:11.0pt;color:black' lang=3Den-US>&nbsp;</p>

<ul type=3Ddisc style=3D'direction:ltr;unicode-bidi:embed;margin-top:0in;
 margin-bottom:0in'>
 <li style=3D'margin-top:0;margin-bottom:0;vertical-align:middle' lang=3Den=
-US><span
     style=3D'font-family:"Microsoft JhengHei";font-size:16.0pt;color:black=
'>根據
     2022 年台灣動脈硬化學會（TAS）指南，針對動脈粥樣=
化性心血管疾病（ASCVD）的LDL-C目標值如下：</span></li>
 <ul type=3Dcircle style=3D'direction:ltr;unicode-bidi:embed;margin-top:0in;
  margin-bottom:0in'>
  <li style=3D'margin-top:0;margin-bottom:0;vertical-align:middle;color:bla=
ck'
      lang=3Den-US><span style=3D'font-family:"Microsoft JhengHei";font-siz=
e:14.0pt'>LDL-C目標值依據ASCVD風險分層</span></li>
 </ul>
</ul>

<div style=3D'direction:ltr'>

<table border=3D1 cellpadding=3D0 cellspacing=3D0 valign=3Dtop style=3D'dir=
ection:ltr;
 border-collapse:collapse;border-style:solid;border-color:#A3A3A3;border-wi=
dth:
 1pt;margin-left:.3333in' title=3D"" summary=3D"">
 <tr>
  <td style=3D'border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:1.2458in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style=3D'margin:0in;font-family:"Microsoft JhengHei";font-size:11.0pt;
  color:black;text-align:center' lang=3Den-US>風險等級</p>
  </td>
  <td style=3D'border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:4.3375in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style=3D'margin:0in;font-family:"Microsoft JhengHei";font-size:11.0pt;
  color:black;text-align:center' lang=3Den-US>定義</p>
  </td>
  <td style=3D'border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:1.9187in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style=3D'margin:0in;font-family:"Microsoft JhengHei";font-size:11.0pt;
  color:black;text-align:center'>LDL-C 目標值</p>
  </td>
 </tr>
 <tr>
  <td style=3D'border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:1.2458in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style=3D'margin:0in;font-family:"Microsoft JhengHei";font-size:11.0pt;
  color:black'>極高風險（Very High Risk）</p>
  </td>
  <td style=3D'border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:4.3375in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style=3D'margin:0in;font-family:"Microsoft JhengHei";font-size:11.0pt;
  color:black'>已確診 ASCVD（如心肌梗塞、腦中風、周邊動脈=
疾病），或 糖尿病 + 靶器官損害（如微量白蛋白尿）</p>
  </td>
  <td style=3D'border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:1.9187in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style=3D'margin:0in;font-family:"Microsoft JhengHei";font-size:11.0pt;
  color:black'>&lt; 55 mg/dL（1.4 mmol/L） 且降幅 ≥ 50%</p>
  </td>
 </tr>
 <tr>
  <td style=3D'border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:1.2458in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style=3D'margin:0in;font-family:"Microsoft JhengHei";font-size:11.0pt;
  color:black'>高風險（High Risk）</p>
  </td>
  <td style=3D'border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:4.3423in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style=3D'margin:0in;font-family:"Microsoft JhengHei";font-size:11.0pt;
  color:black'>糖尿病（無靶器官損害）、慢性腎病（CKD stage=
 3-4）、10 年風險 &gt; 20%</p>
  </td>
  <td style=3D'border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:1.9187in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style=3D'margin:0in;font-family:"Microsoft JhengHei";font-size:11.0pt;
  color:black'>&lt; 70 mg/dL（1.8 mmol/L） 且降幅 ≥ 50%</p>
  </td>
 </tr>
 <tr>
  <td style=3D'border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:1.2458in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style=3D'margin:0in;font-family:"Microsoft JhengHei";font-size:11.0pt;
  color:black'>中等風險（Moderate Risk）</p>
  </td>
  <td style=3D'border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:4.3569in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style=3D'margin:0in;font-family:"Microsoft JhengHei";font-size:11.0pt;
  color:black'>2 個以上心血管危險因子（高血壓、吸菸、家=
史等），10 年風險 10-20%</p>
  </td>
  <td style=3D'border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:1.9187in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style=3D'margin:0in;font-family:"Microsoft JhengHei";font-size:11.0pt;
  color:black'>&lt; 100 mg/dL（2.6 mmol/L）</p>
  </td>
 </tr>
 <tr>
  <td style=3D'border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:1.2458in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style=3D'margin:0in;font-family:"Microsoft JhengHei";font-size:11.0pt;
  color:black'>低風險（Low Risk）</p>
  </td>
  <td style=3D'border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:4.3375in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style=3D'margin:0in;font-family:"Microsoft JhengHei";font-size:11.0pt;
  color:black'><span lang=3Den-US>無主要心血管危險因子或僅有 1=
 個危險因子，</span><span lang=3Dzh-TW>10
  年風險 &lt; 10%</span></p>
  </td>
  <td style=3D'border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:1.9187in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style=3D'margin:0in;font-family:"Microsoft JhengHei";font-size:11.0pt;
  color:black'>&lt; 130 mg/dL（3.4 mmol/L）</p>
  </td>
 </tr>
</table>

</div>

<p style=3D'margin:0in;margin-left:.375in;font-family:"Microsoft JhengHei";
font-size:11.0pt' lang=3Den-US>&nbsp;</p>

<ul type=3Ddisc style=3D'direction:ltr;unicode-bidi:embed;margin-top:0in;
 margin-bottom:0in'>
 <li style=3D'margin-top:0;margin-bottom:0;vertical-align:middle;color:blac=
k'><span
     style=3D'font-family:"Microsoft JhengHei";font-size:16.0pt'>治療（T=
reatment）：</span></li>
 <ul type=3Dcircle style=3D'direction:ltr;unicode-bidi:embed;margin-top:0in;
  margin-bottom:0in'>
  <li style=3D'margin-top:0;margin-bottom:0;vertical-align:middle;color:bla=
ck'
      lang=3Den-US><span style=3D'font-family:"Microsoft JhengHei";font-siz=
e:14.0pt;
      color:black'>治療主要分為</span><span style=3D'font-family:"Mic=
rosoft JhengHei";
      font-size:14.0pt;color:#C00000'>生活方式調整（Lifestyle
      Modification）與藥物治療（Pharmacologic Therapy）</span><span=
 style=3D'font-family:
      "Microsoft JhengHei";font-size:14.0pt;color:black'>。</span></li>
 </ul>
 <ul type=3Dcircle style=3D'direction:ltr;unicode-bidi:embed;margin-top:0in;
  margin-bottom:0in'>
  <li style=3D'margin-top:0;margin-bottom:0;vertical-align:middle' lang=3De=
n-US><span
      style=3D'font-family:"Microsoft JhengHei";font-size:14.0pt;color:blac=
k'>生活方式調整（適用所有患者）：</span></li>
  <ul type=3Ddisc style=3D'direction:ltr;unicode-bidi:embed;margin-top:0in;
   margin-bottom:0in'>
   <li style=3D'margin-top:0;margin-bottom:0;vertical-align:middle;color:bl=
ack'
       lang=3Den-US><span style=3D'font-family:"Microsoft JhengHei";font-si=
ze:11.0pt'>低脂飲食（減少紅肉攝取，增加膳食纖維）</span>=
</li>
   <li style=3D'margin-top:0;margin-bottom:0;vertical-align:middle;color:bl=
ack'
       lang=3Den-US><span style=3D'font-family:"Microsoft JhengHei";font-si=
ze:11.0pt'>規律有氧運動</span></li>
   <li style=3D'margin-top:0;margin-bottom:0;vertical-align:middle;color:bl=
ack'
       lang=3Den-US><span style=3D'font-family:"Microsoft JhengHei";font-si=
ze:11.0pt'>減重</span></li>
  </ul>
 </ul>
 <ul type=3Dcircle style=3D'direction:ltr;unicode-bidi:embed;margin-top:0in;
  margin-bottom:0in'>
  <li style=3D'margin-top:0;margin-bottom:0;vertical-align:middle;margin-to=
p:
      5pt;margin-bottom:5pt;color:black' lang=3Den-US><span style=3D'font-f=
amily:
      "Microsoft JhengHei";font-size:14.0pt'>藥物治療指引（依據 Am=
erican College of
      Cardiology/American Heart Association）</span></li>
  <ul type=3Ddisc style=3D'direction:ltr;unicode-bidi:embed;margin-top:0in;
   margin-bottom:0in'>
   <li style=3D'margin-top:0;margin-bottom:0;vertical-align:middle;margin-t=
op:
       5pt;margin-bottom:5pt;color:black' lang=3Den-US><span style=3D'font-=
weight:
       bold;font-family:"Microsoft JhengHei";font-size:11.0pt;color:#70AD47=
'>Statins（他汀類）為首選藥物</span></li>
   <li style=3D'margin-top:0;margin-bottom:0;vertical-align:middle;color:bl=
ack'
       lang=3Den-US><span style=3D'font-family:"Microsoft JhengHei";font-si=
ze:11.0pt'>高強度
       Statin（降低 LDL-C &gt;50%）：</span></li>
   <ul type=3Ddisc style=3D'direction:ltr;unicode-bidi:embed;margin-top:0in;
    margin-bottom:0in'>
    <li style=3D'margin-top:0;margin-bottom:0;vertical-align:middle;color:b=
lack'
        lang=3Den-US><span style=3D'font-family:"Microsoft JhengHei";font-s=
ize:
        11.0pt'>Atorvastatin 40–80 mg</span></li>
    <li style=3D'margin-top:0;margin-bottom:0;vertical-align:middle;color:b=
lack'
        lang=3Den-US><span style=3D'font-family:"Microsoft JhengHei";font-s=
ize:
        11.0pt'>Rosuvastatin 20–40 mg</span></li>
   </ul>
   <li style=3D'margin-top:0;margin-bottom:0;vertical-align:middle;color:bl=
ack'
       lang=3Den-US><span style=3D'font-family:"Microsoft JhengHei";font-si=
ze:11.0pt'>中等強度
       Statin（降低 LDL-C 30%–50%）</span></li>
   <li style=3D'margin-top:0;margin-bottom:0;vertical-align:middle;margin-t=
op:
       5pt;margin-bottom:5pt;color:black' lang=3Den-US><span style=3D'font-=
family:
       "Microsoft JhengHei";font-size:11.0pt'>高三酸甘油酯血症治=
</span></li>
   <ul type=3Ddisc style=3D'direction:ltr;unicode-bidi:embed;margin-top:0in;
    margin-bottom:0in'>
    <li style=3D'margin-top:0;margin-bottom:0;vertical-align:middle;margin-=
top:
        5pt;margin-bottom:5pt;color:black' lang=3Den-US><span style=3D'font=
-family:
        "Microsoft JhengHei";font-size:11.0pt'>初始治療：生活方式=
整、治療繼發性病因（如糖尿病、慢性腎病）</span></li>
    <li style=3D'margin-top:0;margin-bottom:0;vertical-align:middle;margin-=
top:
        5pt;margin-bottom:5pt;color:black'><span style=3D'font-family:"Micr=
osoft JhengHei";
        font-size:11.0pt' lang=3Den-US>若 ASCVD 風險 </span><span style=
=3D'font-family:
        "Microsoft JhengHei Light";font-size:11.0pt' lang=3D"x-IV_mathan">=
</span><span
        style=3D'font-family:"Microsoft JhengHei";font-size:11.0pt' lang=3D=
en-US>7.5%，可考慮
        statins</span></li>
    <li style=3D'margin-top:0;margin-bottom:0;vertical-align:middle;margin-=
top:
        5pt;margin-bottom:5pt;color:black'><span style=3D'font-family:"Micr=
osoft JhengHei";
        font-size:11.0pt' lang=3Den-US>預防胰臟炎（triglycerides </sp=
an><span
        style=3D'font-family:"Microsoft JhengHei Light";font-size:11.0pt'
        lang=3D"x-IV_mathan">≥</span><span style=3D'font-family:"Microsof=
t JhengHei";
        font-size:11.0pt' lang=3Den-US>1000 mg/dL）：Fibrate（貝特類=
物）</span></li>
   </ul>
  </ul>
 </ul>
</ul>

<p style=3D'margin-left:.375in;margin-top:5pt;margin-bottom:5pt;font-family=
:"Microsoft JhengHei";
font-size:11.0pt;color:black' lang=3Den-US>&nbsp;</p>

<ul type=3Ddisc style=3D'direction:ltr;unicode-bidi:embed;margin-top:0in;
 margin-bottom:0in'>
 <li style=3D'margin-top:0;margin-bottom:0;vertical-align:middle;margin-top=
:5pt;
     margin-bottom:5pt;color:black' lang=3Den-US><span style=3D'font-family=
:"Microsoft JhengHei";
     font-size:16.0pt'>Dyslipidemia 藥物整理</span></li>
</ul>

<div style=3D'direction:ltr'>

<table border=3D1 cellpadding=3D0 cellspacing=3D0 valign=3Dtop style=3D'dir=
ection:ltr;
 border-collapse:collapse;border-style:solid;border-color:#A3A3A3;border-wi=
dth:
 1pt;margin-left:.3333in' title=3D"" summary=3D"">
 <tr>
  <td style=3D'border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:1.0763in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style=3D'margin:0in;font-family:"Microsoft JhengHei";font-size:11.0pt;
  color:black;text-align:center'>藥物類別</p>
  </td>
  <td style=3D'border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:1.3916in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style=3D'margin:0in;font-family:"Microsoft JhengHei";font-size:11.0pt;
  color:black;text-align:center'>代表藥物</p>
  </td>
  <td style=3D'border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:1.1965in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style=3D'margin:0in;font-family:"Microsoft JhengHei";font-size:11.0pt;
  color:black;text-align:center'>作用機轉</p>
  </td>
  <td style=3D'border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:1.1486in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style=3D'margin:0in;font-family:"Microsoft JhengHei";font-size:11.0pt;
  color:black;text-align:center'>適應症</p>
  </td>
  <td style=3D'border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:1.5479in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style=3D'margin:0in;font-family:"Microsoft JhengHei";font-size:11.0pt;
  color:black;text-align:center'>主要副作用</p>
  </td>
  <td style=3D'border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:1.3902in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style=3D'margin:0in;font-family:"Microsoft JhengHei";font-size:11.0pt;
  color:black;text-align:center'>考點</p>
  </td>
 </tr>
 <tr>
  <td style=3D'border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:1.0763in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style=3D'margin:0in;font-family:"Microsoft JhengHei";font-size:11.0pt;
  color:black'>Statins</p>
  </td>
  <td style=3D'border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:1.3916in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style=3D'margin:0in;font-family:"Microsoft JhengHei";font-size:11.0pt;
  color:black'>Atorvastatin, Rosuvastatin</p>
  </td>
  <td style=3D'border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:1.2152in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style=3D'margin:0in;font-family:"Microsoft JhengHei";font-size:11.0pt;
  color:black'>抑制HMG-CoA reductase，降低肝臟膽固醇合成，增=
LDL受體 表現</p>
  </td>
  <td style=3D'border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:1.168in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style=3D'margin:0in;font-family:"Microsoft JhengHei";font-size:11.0pt;
  color:black'>高LDL-C（首選）、ASCVD 預防</p>
  </td>
  <td style=3D'border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:1.5479in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style=3D'margin:0in;font-family:"Microsoft JhengHei";font-size:11.0pt;
  color:black'>肝毒性、肌肉病變（CK ↑）</p>
  </td>
  <td style=3D'border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:1.4944in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style=3D'margin:0in;font-family:"Microsoft JhengHei";font-size:11.0pt;
  color:black'>首選藥物，Statin + Fibrate → 肌肉毒性</p>
  <p style=3D'margin:0in;font-family:"Microsoft JhengHei";font-size:11.0pt;
  color:red' lang=3Den-US>↓LDL </p>
  </td>
 </tr>
 <tr>
  <td style=3D'border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:1.0958in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style=3D'margin:0in;font-family:"Microsoft JhengHei";font-size:11.0pt;
  color:black' lang=3Den-US>Bile Acid Sequestrants（膽酸螯合劑）</p>
  </td>
  <td style=3D'border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:1.3965in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style=3D'margin:0in;font-family:"Microsoft JhengHei";font-size:11.0pt;
  color:black' lang=3Den-US>Cholestyramine, Colesevelam</p>
  </td>
  <td style=3D'border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:1.1965in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style=3D'margin:0in;font-family:"Microsoft JhengHei";font-size:11.0pt;
  color:black' lang=3Den-US>與膽酸結合，促使膽固醇轉化為膽=
</p>
  </td>
  <td style=3D'border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:1.1555in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style=3D'margin:0in;font-family:"Microsoft JhengHei";font-size:11.0pt;
  color:black' lang=3Den-US>適合年輕患者或孕婦的高膽固醇血=
</p>
  </td>
  <td style=3D'border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:1.5673in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style=3D'margin:0in;font-family:"Microsoft JhengHei";font-size:11.0pt;
  color:black' lang=3Den-US>胃腸不適（便秘、腹脹）、可能影=
脂溶性維生素吸收</p>
  </td>
  <td style=3D'border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:1.3194in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style=3D'margin:0in;font-family:"Microsoft JhengHei";font-size:11.0pt;
  color:red' lang=3Den-US>↓LDL</p>
  <p style=3D'margin:0in;font-family:"Microsoft JhengHei";font-size:11.0pt'
  lang=3Den-US><span style=3D'color:black'>輕微</span><span style=3D'colo=
r:red'>↑HDL</span></p>
  </td>
 </tr>
 <tr>
  <td style=3D'border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:1.0763in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style=3D'margin:0in;font-family:"Microsoft JhengHei";font-size:11.0pt;
  color:black'>Fibrates</p>
  </td>
  <td style=3D'border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:1.3916in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style=3D'margin:0in;font-family:"Microsoft JhengHei";font-size:11.0pt;
  color:black'>Gemfibrozil, Fenofibrate</p>
  </td>
  <td style=3D'border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:1.2152in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style=3D'margin:0in;font-family:"Microsoft JhengHei";font-size:11.0pt;
  color:black'>活化PPAR-α，增加 LPL活性，降低VLDL 產生</p>
  </td>
  <td style=3D'border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:1.168in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style=3D'margin:0in;font-family:"Microsoft JhengHei";font-size:11.0pt;
  color:black'>高三酸甘油酯（TG &gt;1000 mg/dL），預防胰臟炎<=
/p>
  </td>
  <td style=3D'border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:1.5673in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style=3D'margin:0in;font-family:"Microsoft JhengHei";font-size:11.0pt;
  color:black'>膽結石（cholelithiasis）、肌肉毒性</p>
  </td>
  <td style=3D'border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:1.4944in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style=3D'margin:0in;font-family:"Microsoft JhengHei";font-size:11.0pt;
  color:black'>TG &gt;1000 mg/dL → Fibrate，Statin + Gemfibrozil → 肌=
肉毒性 ↑</p>
  <p style=3D'margin:0in;font-family:"Microsoft JhengHei";font-size:11.0pt;
  color:red' lang=3Den-US>↓TG </p>
  <p style=3D'margin:0in;font-family:"Microsoft JhengHei";font-size:11.0pt;
  color:red' lang=3Den-US>↑HDL </p>
  </td>
 </tr>
 <tr>
  <td style=3D'border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:1.0763in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style=3D'margin:0in;font-family:"Microsoft JhengHei";font-size:11.0pt;
  color:black'>Niacin</p>
  </td>
  <td style=3D'border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:1.3916in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style=3D'margin:0in;font-family:"Microsoft JhengHei";font-size:11.0pt;
  color:black'>Niacin (Vit B3)</p>
  </td>
  <td style=3D'border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:1.2152in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style=3D'margin:0in;font-family:"Microsoft JhengHei";font-size:11.0pt;
  color:black'>抑制肝臟 VLDL合成，增加HDL</p>
  </td>
  <td style=3D'border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:1.159in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style=3D'margin:0in;font-family:"Microsoft JhengHei";font-size:11.0pt;
  color:black'>提高HDL，輕度高膽固醇血症</p>
  </td>
  <td style=3D'border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:1.5479in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style=3D'margin:0in;font-family:"Microsoft JhengHei";font-size:11.0pt;
  color:black'>潮紅（flushing，PGE 介導）、高尿酸血症（痛風=
）</p>
  </td>
  <td style=3D'border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:1.459in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style=3D'margin:0in;font-family:"Microsoft JhengHei";font-size:11.0pt;
  color:black'>可用 Aspirin減少潮紅反應</p>
  <p style=3D'margin:0in;font-family:"Microsoft JhengHei";font-size:11.0pt;
  color:red' lang=3Den-US>↓TG </p>
  <p style=3D'margin:0in;font-family:"Microsoft JhengHei";font-size:11.0pt;
  color:red' lang=3Den-US>↑HDL</p>
  </td>
 </tr>
 <tr>
  <td style=3D'border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:1.0944in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style=3D'margin:0in;font-family:"Microsoft JhengHei";font-size:11.0pt;
  color:black'>Ezetimibe（膽固醇吸收抑制劑）</p>
  </td>
  <td style=3D'border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:1.3916in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style=3D'margin:0in;font-family:"Microsoft JhengHei";font-size:11.0pt;
  color:black'>Ezetimibe</p>
  </td>
  <td style=3D'border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:1.1986in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style=3D'margin:0in;font-family:"Microsoft JhengHei";font-size:11.0pt;
  color:black'>抑制腸道NPC1L1 transporter，減少膽固醇吸收</p>
  </td>
  <td style=3D'border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:1.1486in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style=3D'margin:0in;font-family:"Microsoft JhengHei";font-size:11.0pt;
  color:black'>高LDL-C（可與 statin 合併）</p>
  </td>
  <td style=3D'border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:1.5479in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style=3D'margin:0in;font-family:"Microsoft JhengHei";font-size:11.0pt;
  color:black'>腹瀉、肝功能異常（罕見）</p>
  </td>
  <td style=3D'border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:1.3902in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style=3D'margin:0in;font-family:"Microsoft JhengHei";font-size:11.0pt;
  color:black'>常與 statins 併用</p>
  <p style=3D'margin:0in;font-family:"Microsoft JhengHei";font-size:11.0pt;
  color:red' lang=3Den-US>↓LDL </p>
  </td>
 </tr>
 <tr>
  <td style=3D'border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:1.0763in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style=3D'margin:0in;font-family:"Microsoft JhengHei";font-size:11.0pt;
  color:black'>PCSK9 inhibitors</p>
  </td>
  <td style=3D'border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:1.3916in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style=3D'margin:0in;font-family:"Microsoft JhengHei";font-size:11.0pt;
  color:black'>Alirocumab, Evolocumab</p>
  </td>
  <td style=3D'border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:1.2in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style=3D'margin:0in;font-family:"Microsoft JhengHei";font-size:11.0pt;
  color:black'>抑制 PCSK9，增加 LDL受體表現</p>
  </td>
  <td style=3D'border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:1.168in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style=3D'margin:0in;font-family:"Microsoft JhengHei";font-size:11.0pt;
  color:black'>家族性高膽固醇血症（FH），無法耐受 statin =
</p>
  </td>
  <td style=3D'border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:1.5673in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style=3D'margin:0in;font-family:"Microsoft JhengHei";font-size:11.0pt;
  color:black'>注射部位反應，罕見肝功能異常</p>
  </td>
  <td style=3D'border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:1.4944in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style=3D'margin:0in;font-family:"Microsoft JhengHei";font-size:11.0pt;
  color:black'>高風險患者（如家族性高膽固醇血症）適用</p>
  <p style=3D'margin:0in;font-family:"Microsoft JhengHei";font-size:11.0pt;
  color:red' lang=3Den-US>↓LDL </p>
  </td>
 </tr>
 <tr>
  <td style=3D'border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:1.0958in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style=3D'margin:0in;font-family:"Microsoft JhengHei";font-size:11.0pt;
  color:black'>Omega-3 脂肪酸</p>
  </td>
  <td style=3D'border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:1.3916in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style=3D'margin:0in;font-family:"Microsoft JhengHei";font-size:11.0pt;
  color:black'>Fish oil, Icosapent ethyl</p>
  </td>
  <td style=3D'border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:1.2152in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style=3D'margin:0in;font-family:"Microsoft JhengHei";font-size:11.0pt;
  color:black'>減少肝臟VLDL合成，降低TG</p>
  </td>
  <td style=3D'border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:1.1555in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style=3D'margin:0in;font-family:"Microsoft JhengHei";font-size:11.0pt;
  color:black'>中等程度高三酸甘油酯血症（TG 200–500 mg/dL）=
</p>
  </td>
  <td style=3D'border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:1.5673in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style=3D'margin:0in;font-family:"Microsoft JhengHei";font-size:11.0pt;
  color:black'>胃腸不適、魚腥味回流</p>
  <p style=3D'margin:0in;font-family:"Microsoft JhengHei";font-size:11.0pt;
  color:black'>&nbsp;</p>
  </td>
  <td style=3D'border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:1.4618in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style=3D'margin:0in;font-family:"Microsoft JhengHei";font-size:11.0pt;
  color:black'>降低 TG，但效果不如fibrates</p>
  <p style=3D'margin:0in;font-family:"Microsoft JhengHei";font-size:11.0pt;
  color:red' lang=3Den-US>↓TG </p>
  </td>
 </tr>
 <tr>
  <td style=3D'border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:1.0958in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style=3D'margin:0in;font-family:"Microsoft JhengHei";font-size:11.0pt;
  color:black' lang=3Den-US>MTP（Microsomal Triglyceride Transfer Protein=
抑制劑</p>
  </td>
  <td style=3D'border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:1.3916in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style=3D'margin:0in;font-family:"Microsoft JhengHei";font-size:11.0pt;
  color:black' lang=3Den-US>Lomitapide</p>
  </td>
  <td style=3D'border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:1.2152in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style=3D'margin:0in;font-family:"Microsoft JhengHei";font-size:11.0pt;
  color:black' lang=3Den-US>抑制 microsomal triglyceride transfer protein=
（MTP），減少
  VLDL 產生</p>
  </td>
  <td style=3D'border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:1.168in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style=3D'margin:0in;font-family:"Microsoft JhengHei";font-size:11.0pt;
  color:black' lang=3Den-US>家族性高膽固醇血症，適合 Statins =
 PCSK9 抑制劑效果不佳的患者</p>
  </td>
  <td style=3D'border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:1.5673in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style=3D'margin:0in;font-family:"Microsoft JhengHei";font-size:11.0pt;
  color:black' lang=3Den-US>噁心、腹瀉、肝內脂肪堆積（脂肪=
）</p>
  </td>
  <td style=3D'border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:1.4944in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style=3D'margin:0in;font-family:"Microsoft JhengHei";font-size:11.0pt;
  color:black' lang=3Den-US>口服劑型，但 GI 副作用明顯，需低=
飲食以減少腸胃不適。需監測肝酶（ALT/AST），避免嚴重=
肝毒性。</p>
  <p style=3D'margin:0in;font-family:"Microsoft JhengHei";font-size:11.0pt;
  color:red' lang=3Den-US>↓LDL </p>
  <p style=3D'margin:0in;font-family:"Microsoft JhengHei";font-size:11.0pt;
  color:black'>&nbsp;</p>
  </td>
 </tr>
 <tr>
  <td style=3D'border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:1.0763in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style=3D'margin:0in;font-family:"Microsoft JhengHei";font-size:11.0pt;
  color:black' lang=3Den-US>ApoB-100 抑制劑</p>
  </td>
  <td style=3D'border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:1.3916in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style=3D'margin:0in;font-family:"Microsoft JhengHei";font-size:11.0pt;
  color:black' lang=3Den-US>Mipomersen</p>
  </td>
  <td style=3D'border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:1.1965in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style=3D'margin:0in;font-family:"Microsoft JhengHei";font-size:11.0pt;
  color:black' lang=3Den-US>抑制 ApoB-100 mRNA，減少 VLDL 和 LDL 生=
</p>
  </td>
  <td style=3D'border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:1.168in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style=3D'margin:0in;font-family:"Microsoft JhengHei";font-size:11.0pt;
  color:black' lang=3Den-US>家族性高膽固醇血症，適合 Statins =
 PCSK9 抑制劑效果不佳的患者</p>
  </td>
  <td style=3D'border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:1.5673in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style=3D'margin:0in;font-family:"Microsoft JhengHei";font-size:11.0pt;
  color:black' lang=3Den-US>注射部位反應、類流感症狀、肝內=
肪堆積（脂肪肝）</p>
  </td>
  <td style=3D'border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:1.4944in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style=3D'margin:0in;font-family:"Microsoft JhengHei";font-size:11.0pt;
  color:black' lang=3Den-US>皮下注射，常見注射部位反應，但=
要問題是肝脂肪增加，可能影響肝功能。需監測肝酶（AL=
T/AST），避免嚴重肝毒性。</p>
  <p style=3D'margin:0in;font-family:"Microsoft JhengHei";font-size:11.0pt;
  color:red' lang=3Den-US>↓LDL </p>
  <p style=3D'margin:0in;font-family:Calibri;font-size:11.0pt;color:black'
  lang=3Den-US>&nbsp;</p>
  </td>
 </tr>
</table>

</div>

<ul type=3Dcircle style=3D'direction:ltr;unicode-bidi:embed;margin-top:0in;
 margin-bottom:0in'>
 <li style=3D'margin-top:0;margin-bottom:0;vertical-align:middle;color:blac=
k'
     lang=3Den-US><span style=3D'font-family:"Microsoft JhengHei";font-size=
:14.0pt'>Statins
     仍為第一線藥物，但若 LDL 降幅不足，可加用 Ezetimibe =
或 PCSK9 抑制劑。</span></li>
 <li style=3D'margin-top:0;margin-bottom:0;vertical-align:middle;color:blac=
k'
     lang=3Den-US><span style=3D'font-family:"Microsoft JhengHei";font-size=
:14.0pt'>TG
     &gt; 500 mg/dL 時，優先使用 Fibrates 或 Omega-3，避免胰臟=
風險。</span></li>
</ul>

<p style=3D'margin:0in;font-family:"Microsoft JhengHei";font-size:16.0pt;
color:black'>&nbsp;</p>

<ul type=3Ddisc style=3D'direction:ltr;unicode-bidi:embed;margin-top:0in;
 margin-bottom:0in'>
 <li style=3D'margin-top:0;margin-bottom:0;vertical-align:middle;color:blac=
k'><span
     style=3D'font-family:"Microsoft JhengHei";font-size:16.0pt'>依風險=
級的治療策略</span></li>
</ul>

<div style=3D'direction:ltr'>

<table border=3D1 cellpadding=3D0 cellspacing=3D0 valign=3Dtop style=3D'dir=
ection:ltr;
 border-collapse:collapse;border-style:solid;border-color:#A3A3A3;border-wi=
dth:
 1pt;margin-left:.3333in' title=3D"" summary=3D"">
 <tr>
  <td style=3D'border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:3.7354in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style=3D'margin:0in;font-family:"Microsoft JhengHei";font-size:11.0pt;
  color:black;text-align:center'>風險族群</p>
  </td>
  <td style=3D'border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:3.2298in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style=3D'margin:0in;font-family:"Microsoft JhengHei";font-size:11.0pt;
  color:black;text-align:center'>治療策略</p>
  </td>
 </tr>
 <tr>
  <td style=3D'border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:3.7354in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style=3D'margin:0in;font-family:"Microsoft JhengHei";font-size:11.0pt;
  color:black'>低風險（LDL &lt; 130 mg/dL）</p>
  </td>
  <td style=3D'border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:3.2298in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style=3D'margin:0in;font-family:"Microsoft JhengHei";font-size:11.0pt;
  color:black'>生活方式調整</p>
  </td>
 </tr>
 <tr>
  <td style=3D'border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:3.7354in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style=3D'margin:0in;font-family:"Microsoft JhengHei";font-size:11.0pt;
  color:black'>中等風險（LDL 100-129 mg/dL）</p>
  </td>
  <td style=3D'border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:3.2298in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style=3D'margin:0in;font-family:"Microsoft JhengHei";font-size:11.0pt;
  color:black'>生活方式調整，考慮 Statins</p>
  </td>
 </tr>
 <tr>
  <td style=3D'border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:3.7548in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style=3D'margin:0in;font-family:"Microsoft JhengHei";font-size:11.0pt;
  color:black'>高風險（LDL ≥ 100 mg/dL，ASCVD 風險 ≥ 7.5%）</p>
  </td>
  <td style=3D'border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:3.2798in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style=3D'margin:0in;font-family:"Microsoft JhengHei";font-size:11.0pt;
  color:black'>Statins 第一線，若 LDL 不達標可加 Ezetimibe</p>
  </td>
 </tr>
 <tr>
  <td style=3D'border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:3.7354in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style=3D'margin:0in;font-family:"Microsoft JhengHei";font-size:11.0pt;
  color:black'>極高風險（LDL ≥ 70 mg/dL，已有 ASCVD 或 FH）</p>
  </td>
  <td style=3D'border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:3.2298in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style=3D'margin:0in;font-family:"Microsoft JhengHei";font-size:11.0pt;
  color:black'>強效 Statins + Ezetimibe ± PCSK9 抑制劑</p>
  </td>
 </tr>
</table>

</div>

<p style=3D'margin:0in;font-family:"Microsoft JhengHei";font-size:11.0pt;
color:black' lang=3Den-US>&nbsp;</p>

<p style=3D'margin:0in;font-family:"Microsoft JhengHei";font-size:11.0pt;
color:black' lang=3Den-US>REFERENCE：</p>

<ol type=3D1 style=3D'direction:ltr;unicode-bidi:embed;margin-top:0in;margi=
n-bottom:
 0in;font-family:Calibri;font-size:11.0pt;font-weight:normal;font-style:nor=
mal'>
 <li value=3D1 style=3D'margin-top:0;margin-bottom:0;vertical-align:middle'
     lang=3Den-US><span style=3D'font-family:Calibri;font-size:11.0pt;font-=
weight:
     normal;font-style:normal;font-family:Calibri;font-size:11.0pt'>HARRISON
     Principles of Internal Medicine 20th Edition</span></li>
</ol>

<ol type=3D1 style=3D'direction:ltr;unicode-bidi:embed;margin-top:0in;margi=
n-bottom:
 0in;font-family:Calibri;font-size:11.0pt;font-weight:normal;font-style:nor=
mal'>
 <li value=3D2 style=3D'margin-top:0;margin-bottom:0;vertical-align:middle'
     lang=3Den-US><span style=3D'font-family:Calibri;font-size:11.0pt;font-=
weight:
     normal;font-style:normal;font-family:Calibri;font-size:11.0pt'>Boards
     &amp; Beyonds</span><span style=3D'font-family:"Microsoft JhengHei";
     font-size:11.0pt;font-weight:normal;font-style:normal;font-family:"Mic=
rosoft JhengHei";
     font-size:11.0pt'>：</span><span style=3D'font-family:Calibri;font-si=
ze:11.0pt;
     font-weight:normal;font-style:normal;font-family:Calibri;font-size:11.=
0pt'>Dyslipidemia</span></li>
 <li style=3D'margin-top:0;margin-bottom:0;vertical-align:middle'><a
     href=3D"https://www.tas.org.tw/upload/files/1-s2_0-S0929664622001036-m=
ain.pdf"><span
     style=3D'font-family:Calibri;font-size:11.0pt' lang=3Den-US>https://ww=
w.tas.org.tw/upload/files/1-s2_0-S0929664622001036-main.pdf</span></a></li>
 <li style=3D'margin-top:0;margin-bottom:0;vertical-align:middle'><a
     href=3D"https://www.tas.org.tw/upload/files/1-s2_0-S0929664622002157-m=
ain%20(1).pdf"><span
     style=3D'font-family:Calibri;font-size:11.0pt' lang=3Den-US>https://ww=
w.tas.org.tw/upload/files/1-s2_0-S0929664622002157-main%20(1).pdf</span></a=
></li>
</ol>

</div>

<div style=3D'direction:ltr;margin-top:5.6659in;margin-left:.05in;width:6.8=
25in'>

<p style=3D'margin:0in;font-family:"Microsoft JhengHei";font-size:16.0pt;
color:#C00000'>建議：</p>

<p style=3D'margin:0in;font-family:Calibri;font-size:16.0pt;color:#C00000'>=
&nbsp;</p>

<p style=3D'margin:0in;font-family:Calibri;font-size:16.0pt;color:#C00000'>=
&nbsp;</p>

<p style=3D'margin:0in;font-family:"Microsoft JhengHei";font-size:16.0pt;
color:#C00000'>請問現行台灣關於/高危險/中危險/以及最近12=
月有過Stroke&amp;stenosis活著AF患者的LDL/TG的下降要求量是=
少？</p>

<p style=3D'margin:0in;font-family:Calibri;font-size:16.0pt;color:#C00000'>=
&nbsp;</p>

<p style=3D'margin:0in;font-family:Calibri;font-size:16.0pt;color:#C00000'>=
&nbsp;</p>

<h3 style=3D'margin:0in;font-family:"Microsoft JhengHei";font-size:12.0pt;
color:black'>歐洲心臟學會（ESC）/歐洲動脈硬化學會（EAS）2=
019 年脂質異常治療指引</h3>

<div style=3D'direction:ltr'>

<table border=3D1 cellpadding=3D0 cellspacing=3D0 valign=3Dtop style=3D'dir=
ection:ltr;
 border-collapse:collapse;border-style:solid;border-color:#A3A3A3;border-wi=
dth:
 1pt' title=3D"" summary=3D"">
 <tr>
  <td style=3D'border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:4.7034in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style=3D'margin:0in;font-family:"Microsoft JhengHei";font-size:11.0pt;
  text-align:center'><span style=3D'font-weight:bold'>風險分類</span></=
p>
  </td>
  <td style=3D'border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:1.0041in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style=3D'margin:0in;font-family:Calibri;font-size:11.0pt;text-align:ce=
nter'><span
  style=3D'font-weight:bold'>LDL-C 目標值</span></p>
  </td>
  <td style=3D'border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:.9875in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style=3D'margin:0in;font-family:"Microsoft JhengHei";font-size:11.0pt;
  text-align:center'><span style=3D'font-weight:bold'>相對降低幅度</s=
pan></p>
  </td>
 </tr>
 <tr>
  <td style=3D'border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:4.7034in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style=3D'margin:0in;font-family:"Microsoft JhengHei";font-size:11.0pt'=
>非常高風險（如：已知
  ASCVD、糖尿病合併器官損害、嚴重慢性腎病）</p>
  </td>
  <td style=3D'border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:1.0041in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style=3D'margin:0in;font-family:Calibri;font-size:11.0pt'>&lt; 55 mg/d=
L</p>
  </td>
  <td style=3D'border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:.8986in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style=3D'margin:0in;font-family:Calibri;font-size:11.0pt'>≥ 50% 降=
</p>
  </td>
 </tr>
 <tr>
  <td style=3D'border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:4.7034in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style=3D'margin:0in;font-family:"Microsoft JhengHei";font-size:11.0pt'=
>高風險（如：顯著升高的單一危險因子）</p>
  </td>
  <td style=3D'border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:1.0041in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style=3D'margin:0in;font-family:Calibri;font-size:11.0pt'>&lt; 70 mg/d=
L</p>
  </td>
  <td style=3D'border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:.8986in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style=3D'margin:0in;font-family:Calibri;font-size:11.0pt'>≥ 50% 降=
</p>
  </td>
 </tr>
 <tr>
  <td style=3D'border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:4.7034in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style=3D'margin:0in;font-family:"Microsoft JhengHei";font-size:11.0pt'=
>中等風險</p>
  </td>
  <td style=3D'border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:1.0138in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style=3D'margin:0in;font-family:Calibri;font-size:11.0pt'>&lt; 100 mg/=
dL</p>
  </td>
  <td style=3D'border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:.8611in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style=3D'margin:0in;font-family:Calibri;font-size:11.0pt'>-</p>
  </td>
 </tr>
 <tr>
  <td style=3D'border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:4.7034in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style=3D'margin:0in;font-family:"Microsoft JhengHei";font-size:11.0pt'=
>低風險</p>
  </td>
  <td style=3D'border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:1.0138in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style=3D'margin:0in;font-family:Calibri;font-size:11.0pt'>&lt; 116 mg/=
dL</p>
  </td>
  <td style=3D'border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:.8611in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style=3D'margin:0in;font-family:Calibri;font-size:11.0pt'>-</p>
  </td>
 </tr>
</table>

</div>

<p style=3D'margin-top:5pt;margin-bottom:5pt;font-family:Calibri;font-size:=
16.0pt;
color:black'><span style=3D'font-weight:bold'>TG 控制目標</span>：ESC/=
EAS 指南建議將 TG
水平控制在 &lt; 150 mg/dL，特別是對於高風險患者。</p>

<p style=3D'margin:0in;font-family:"Microsoft JhengHei";font-size:16.0pt;
color:#C00000'>那台灣呢？</p>

</div>

</div>

</div>

<div>

<p style=3D'margin:0in'>&nbsp;</p>

<p style=3D'text-align:left;margin:0in;font-family:Arial;font-size:9pt;
color:#969696;direction:ltr'>使用 OneNote 建立。</p>

</div>

</body>

</html>
